Skip to content
★ Sign in to follow
Curiox Biosystems Co., Ltd logo

Curiox Biosystems Co., Ltd Stock: price and insider trades · South Korea

큐리옥스바이오시스템즈

KR·Mcap ₩786.2BHealth Care

No insider purchase over the last 90 days. The latest, by 박영호, was filed 07 Aug 2026.

Insider Decl.
47
Thresholds
n/a
Buy Volume
€218M
28 ops. · all time
Sell Volume
€60M
7 ops. · all time

Who traded when

BuySale
김남용2 buys4 sales
노희준3 buys1 sale
박영호4 buys
박성철1 buy1 sale
정홍태2 buys
ZIGVenturesLimited1 sale

Since the insiders bought

  • Filed 10 Apr 2026 · 213 days ago · €179k
    -40.4%
    Entry ₩82,500 · Close 03 Nov 2026 ₩49,150
  • Filed 10 Apr 2026 · 213 days ago · €2,945
    -40.4%
    Entry ₩82,500 · Close 03 Nov 2026 ₩49,150
  • Filed 10 Apr 2026 · 213 days ago · €40k
    -40.4%
    Entry ₩82,500 · Close 03 Nov 2026 ₩49,150

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩45,700
Analyst consensus
·
Income statement
Revenue₩5.2B
Gross profit₩2.1B41% margin
EBITDA-₩23.3B-452% margin
Net income-₩27.2B-527.5% margin
Balance sheet & cash
Market cap₩786.2B
Total debt₩2.5B
Free Cash Flow-₩11.2B
Last declaration on 30 October 2026
Declarations52 total
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ▼
    대표이사Executives(filed)
    €23.0Mest.0DART
    570,000 sharesShareKRXDART:20261030000745
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ▼
    대표이사Executives(filed)
    €2.8Mest.0DART
    105,500 sharesShareKRXDART:20260810000735
  • ▲
    전무Executives(filed)
    €76kest.0DART
    3,000 sharesShareKRXDART:20260807000745
    Canonical exit: 5 Nov 2026 (T+90)
  • ▼
    Executives
    €3.1M10DART
    59,342 shares0.68% mcap100.0% of flowKRXDART:20260417000605
  • ▲
    상무Executives
    312M KRW34DART
    16,000 shares@ ₩19,482.000.039% mcap100.0% of flowShareKRXDART:20260410003327
    Canonical exit: 2 Jul 2026 (T+90)
  • ▲
    이사Executives
    5M KRW30DART
    1,164 shares@ ₩4,416.000.0006% mcap100.0% of flowShareKRXDART:20260410003382
    Canonical exit: 2 Jul 2026 (T+90)
  • ●
    부사장Executives
    672M KRW19DART
    22,822 shares@ ₩18,088.57880.085% mcap100.0% of flowShareKRXDART:20260410003357
  • ▲
    전무Executives
    70M KRW34DART
    9,096 shares@ ₩7,729.000.0089% mcap100.0% of flowShareKRXDART:20260410003309
    Canonical exit: 2 Jul 2026 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ▼
    이사Executives(filed)
    €69kest.0DART
    1,000 sharesShareKRXDART:20260130000372
  • ▲
    이사Executives(filed)
    €87kest.0DART
    1,512 sharesShareKRXDART:20251202000203
    Canonical exit: 2 Mar 2026 (T+90)
  • ▲
    대량보유자Executives
    €7.6Mest.0DART
    171,888 sharesKRXDART:20251029000129
    Canonical exit: 20 Jan 2026 (T+90)
  • ▲
    대표이사Executives(filed)
    €8.5Mest.0DART
    191,988 sharesShareKRXDART:20251029000127
    Canonical exit: 27 Jan 2026 (T+90)
  • ▲
    부사장Executives(filed)
    €59kest.0DART
    1,500 sharesShareKRXDART:20250929000424
    Canonical exit: 28 Dec 2025 (T+90)
  • ▲
    전무Executives(filed)
    €24kest.0DART
    600 sharesShareKRXDART:20250929000384
    Canonical exit: 28 Dec 2025 (T+90)
  • ▼
    10%이상주주Executives(filed)
    €12.1Mest.0DART
    472,500 sharesShareKRXDART:20250828000879
  • ▼
    대량보유자Executives
    €18.5Mest.0DART
    703,162 sharesKRXDART:20250827000489
  • ▼
    상무Executives(filed)
    €589kest.0DART
    22,326 sharesShareKRXDART:20250827000532
  • ▲
    부사장Executives(filed)
    €19kest.0DART
    1,500 sharesShareKRXDART:20241219000528
    Canonical exit: 20 Mar 2025 (T+90)
  • ▲
    전무Executives(filed)
    €92kest.0DART
    7,400 sharesShareKRXDART:20241219000498
    Canonical exit: 19 Mar 2025 (T+90)

25 of 52 declarations

About Curiox Biosystems Co., Ltd

The largest trade at 큐리옥스바이오시스템즈 (Curiox Biosystems Co., Ltd) is a sale: EUR 3,087,469, filed by 김남용 on April 16, 2026. On the buying side, three purchases have an amount: EUR 178,611 for 박성철 (상무), EUR 40,284 for 박영호 (전무) and EUR 2,945 for 노희준 (이사), all on April 3, 2026, or EUR 221,840 in all.

김남용, who holds the function 대표이사, is also the most frequent filer: 22 filings, including 9 purchases and 3 sales. The record holds 46 filings from 10 filers, published from August 11, 2023 to August 10, 2026; 28 purchases, 6 sales and 12 filings of another kind, or 82% purchases on the market side.

Read moreShow less

A South Korean health care and pharma company, 큐리옥스바이오시스템즈 is valued at KRW 930.7 billion. Seven distinct filers bought from August 7 to 20, 2024. Filings go from 16 in 2024 to 8 in 2025 and 9 in 2026, and the last twelve months hold 12, of which 7 purchases and 3 sales. The median publication delay is 8 days. For 26 purchases a 90-day result is stored: a median of minus 0.2%, with 31% of results positive, recorded past results and not a forecast.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations